Wordt geladen...
MET and PTEN gene copy numbers and Ki-67 protein expression associate with pathologic complete response in ERBB2-positive breast carcinoma patients treated with neoadjuvant trastuzumab-based therapy
BACKGROUND: Pathologic complete response (pCR) after neoadjuvant chemotherapy for breast cancer is associated with improved prognosis in aggressive tumor subtypes, including ERBB2- positive tumors. Recent adoption of pCR as a surrogate endpoint for clinical trials in early stage breast cancer in the...
Bewaard in:
Gepubliceerd in: | BMC Cancer |
---|---|
Hoofdauteurs: | , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
BioMed Central
2016
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5006506/ https://ncbi.nlm.nih.gov/pubmed/27576528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2743-x |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|